PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis

Background PIK3CA mutations in the helical domain (in exon 9) and in the kinase domain (exon 20) cause tumor formation by different means. We aimed to determine the effects of each of these mutations on survival of colon carcinoma patients.